Stocksigma LogoStocksigma Logo

Akums Drugs Receives Voluntary ESG Rating of 65 for FY26 from NSE Sustainability

On 2nd Sep'26, Akums Drugs and Pharmaceuticals received an ESG rating of 65 for FY26 from NSE Sustainability Ratings & Analytics Limited

Akums Drugs Receives Voluntary ESG Rating of 65 for FY26 from NSE Sustainability

Akums Drugs and Pharmaceuticals Ltd 路 Others (Uncategorized) 路 03 Sept 2026, 8:32 pm

Akums Drugs Receives Voluntary ESG Rating of 65 for FY26 from NSE Sustainability On 2nd Sep'26, Akums Drugs and Pharmaceuticals received an ESG rating of 65 for FY26 from NSE Sustainability Ratings & Analytics Limited. The rating was voluntarily assigned by the agency based solely on publicly available information, as the company did not officially engage NSE Sustainability for this evaluation. This independent ESG assessment provides market participants with a benchmark for the company's environmental, social, and governance practices without active management solicitation.

Original exchange filing (PDF)

More announcements from Akums Drugs and Pharmaceuticals Ltd

All Akums Drugs and Pharmaceuticals Ltd announcements